303 related articles for article (PubMed ID: 30926526)
1. Alginate lyase immobilized chitosan nanoparticles of ciprofloxacin for the improved antimicrobial activity against the biofilm associated mucoid P. aeruginosa infection in cystic fibrosis.
Patel KK; Tripathi M; Pandey N; Agrawal AK; Gade S; Anjum MM; Tilak R; Singh S
Int J Pharm; 2019 May; 563():30-42. PubMed ID: 30926526
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the Thermo-Stability and Anti-Biofilm Activity of Alginate Lyase by Immobilization on Low Molecular Weight Chitosan Nanoparticles.
Li S; Wang Y; Li X; Lee BS; Jung S; Lee MS
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540110
[TBL] [Abstract][Full Text] [Related]
3. Enzyme-Linked Lipid Nanocarriers for Coping Pseudomonal Pulmonary Infection. Would Nanocarriers Complement Biofilm Disruption or Pave Its Road?
Nafee N; Gaber DM; Abouelfetouh A; Alseqely M; Empting M; Schneider M
Int J Nanomedicine; 2024; 19():3861-3890. PubMed ID: 38708178
[TBL] [Abstract][Full Text] [Related]
4. The effect of alginate lyase on the gentamicin resistance of Pseudomonas aeruginosa in mucoid biofilms.
Germoni LA; Bremer PJ; Lamont IL
J Appl Microbiol; 2016 Jul; 121(1):126-35. PubMed ID: 27061817
[TBL] [Abstract][Full Text] [Related]
5. Disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate lyase enhances pathogen eradication by antibiotics.
Daboor SM; Rohde JR; Cheng Z
J Cyst Fibros; 2021 Mar; 20(2):264-270. PubMed ID: 32482592
[TBL] [Abstract][Full Text] [Related]
6. In-vitro evaluation of a ciprofloxacin- and ivacaftor-coated sinus stent against Pseudomonas aeruginosa biofilms.
Cho DY; Lim DJ; Mackey C; Weeks CG; Garcia JAP; Skinner D; Zhang S; McCormick J; Woodworth BA
Int Forum Allergy Rhinol; 2019 May; 9(5):486-492. PubMed ID: 30702211
[TBL] [Abstract][Full Text] [Related]
7. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.
Baelo A; Levato R; Julián E; Crespo A; Astola J; Gavaldà J; Engel E; Mateos-Timoneda MA; Torrents E
J Control Release; 2015 Jul; 209():150-8. PubMed ID: 25913364
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
Deacon J; Abdelghany SM; Quinn DJ; Schmid D; Megaw J; Donnelly RF; Jones DS; Kissenpfennig A; Elborn JS; Gilmore BF; Taggart CC; Scott CJ
J Control Release; 2015 Jan; 198():55-61. PubMed ID: 25481442
[TBL] [Abstract][Full Text] [Related]
9. Marine Bacteria, A Source for Alginolytic Enzyme to Disrupt
Daboor SM; Raudonis R; Cohen A; Rohde JR; Cheng Z
Mar Drugs; 2019 May; 17(5):. PubMed ID: 31137680
[No Abstract] [Full Text] [Related]
10. Cellulophaga algicola alginate lyase inhibits biofilm formation of a clinical Pseudomonas aeruginosa strain MCC 2081.
Mahajan S; Ramya TNC
IUBMB Life; 2021 Feb; 73(2):444-462. PubMed ID: 33350564
[TBL] [Abstract][Full Text] [Related]
11. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance.
Sousa AM; Monteiro R; Pereira MO
Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031
[TBL] [Abstract][Full Text] [Related]
12. Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms.
Alkawash MA; Soothill JS; Schiller NL
APMIS; 2006 Feb; 114(2):131-8. PubMed ID: 16519750
[TBL] [Abstract][Full Text] [Related]
13. Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication.
Wang J; Guo Y; Lu W; Liu X; Zhang J; Sun J; Chai G
Int J Pharm; 2024 Jun; 658():124208. PubMed ID: 38723731
[TBL] [Abstract][Full Text] [Related]
14. Fabrication of inhaled hybrid silver/ciprofloxacin nanoparticles with synergetic effect against Pseudomonas aeruginosa.
Al-Obaidi H; Kalgudi R; Zariwala MG
Eur J Pharm Biopharm; 2018 Jul; 128():27-35. PubMed ID: 29654885
[TBL] [Abstract][Full Text] [Related]
15. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms.
Armijo LM; Wawrzyniec SJ; Kopciuch M; Brandt YI; Rivera AC; Withers NJ; Cook NC; Huber DL; Monson TC; Smyth HDC; Osiński M
J Nanobiotechnology; 2020 Feb; 18(1):35. PubMed ID: 32070354
[TBL] [Abstract][Full Text] [Related]
17. Alginate Lyase Guided Silver Nanocomposites for Eradicating
Wan B; Zhu Y; Tao J; Zhu F; Chen J; Li L; Zhao J; Wang L; Sun S; Yang Y; Zhang X; Zhang Y
ACS Appl Mater Interfaces; 2020 Feb; 12(8):9050-9061. PubMed ID: 32024363
[No Abstract] [Full Text] [Related]
18. Screening, cloning and expression of a novel alginate lyase gene from P. aeruginosa TAG 48 and its antibiofilm effects on P. aeruginosa biofilm.
Tavafi H; Ali AA; Ghadam P; Gharavi S
Microb Pathog; 2018 Nov; 124():356-364. PubMed ID: 30118807
[TBL] [Abstract][Full Text] [Related]
19. In vitro antibacterial activity of ciprofloxacin loaded chitosan microparticles and their effects on human lung epithelial cells.
Kucukoglu V; Uzuner H; Kenar H; Karadenizli A
Int J Pharm; 2019 Oct; 569():118578. PubMed ID: 31362096
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling and redesign of alginate lyase from Pseudomonas aeruginosa for accelerating CRPA biofilm degradation.
Cho H; Huang X; Lan Piao Y; Eun Kim D; Yeon Lee S; Jeong Yoon E; Hee Park S; Lee K; Ho Jang C; Zhan CG
Proteins; 2016 Dec; 84(12):1875-1887. PubMed ID: 27676452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
